We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$6.86B
AUM Growth
-$3.41B
Cap. Flow
-$3.78B
Cap. Flow %
-55.19%
Top 10 Hldgs %
25.96%
Holding
2,871
New
973
Increased
552
Reduced
524
Closed
811

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$378M
2
AMZN icon
Amazon
AMZN
+$336M
3
AAPL icon
Apple
AAPL
+$294M
4
BABA icon
Alibaba
BABA
+$258M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$136M

Sector Composition

Rank Sector Weight
1 Technology 12.92%
2 Consumer Discretionary 8.02%
3 Utilities 7.46%
4 Healthcare 7.42%
5 Financials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
2326
CALL
ICU Medical
ICUI
$4.57B
-10,000
Closed -$2.12M
ICUI icon
2327
ICU Medical
ICUI
$4.57B
-41,137
Closed -$8.82M
IEX icon
2328
IDEX
IEX
$17.3B
-12,108
Closed -$2.41M
IFF icon
2329
International Flavors & Fragrances
IFF
$21.5B
-16,443
Closed -$1.79M
IFS icon
2330
Intercorp Financial Services
IFS
$6.06B
-6,237
Closed -$202K
IHI icon
2331
PUT
iShares US Medical Devices ETF
IHI
$3.49B
-60,000
Closed -$3.27M
INCY icon
2332
Incyte
INCY
$25.9B
-4,771
Closed -$415K
ING icon
2333
ING
ING
$99.5B
-33,784
Closed -$319K
INGN icon
2334
Inogen
INGN
$149M
-9,376
Closed -$419K
INGR icon
2335
Ingredion
INGR
$6.74B
-16,332
Closed -$1.28M
INMD icon
2336
InMode
INMD
$867M
-43,574
Closed -$1.03M
INSE icon
2337
Inspired Entertainment
INSE
$160M
-11,465
Closed -$75K
INVH icon
2338
Invitation Homes
INVH
$17.9B
-114,792
Closed -$3.41M
IOVA icon
2339
Iovance Biotherapeutics
IOVA
$3.76B
-45,671
Closed -$2.12M
IRT icon
2340
Independence Realty Trust
IRT
$3.91B
-13,739
Closed -$185K
IRTC icon
2341
CALL
iRhythm Holdings
IRTC
$4.24B
-10,000
Closed -$2.37M
IRTC icon
2342
iRhythm Holdings
IRTC
$4.24B
-116
Closed -$28K
ITGR icon
2343
PUT
Integer Holdings
ITGR
$4.26B
-10,000
Closed -$812K
ITT icon
2344
ITT
ITT
$18.6B
-13,916
Closed -$1.07M
ITUB icon
2345
Itaú Unibanco
ITUB
$82.4B
-106,497
Closed -$472K
ITW icon
2346
Illinois Tool Works
ITW
$80.4B
-37,169
Closed -$7.58M
IYG icon
2347
iShares US Financial Services ETF
IYG
$2.21B
-4,752
Closed -$238K
J icon
2348
Jacobs Solutions
J
$17.6B
-2,428
Closed -$219K
JBL icon
2349
Jabil
JBL
$32.8B
-49,665
Closed -$2.11M
JD icon
2350
PUT
JD.com
JD
$39.7B
-174,300
Closed -$15.3M

Similar funds

Michael Gelband's Q1 2021 Portfolio in Review

As of Q1 2021, Michael Gelband held 2,871 positions worth $6.86B, down 33% from $10.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.78B in Q1 2021, closing 811 positions and reducing 524 holdings. Its most notable exit was Alibaba, an estimated $258M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Utilities.

Against the trend, Michael Gelband opened a new position in Comcast worth $39.1M.

  • Michael Gelband's largest Q1 2021 buy was Comcast: 722,523 shares worth $39.1M.
  • Michael Gelband added most to iShares Russell 1000 Value ETF in Q1 2021, an estimated $48M increase.
  • Michael Gelband's biggest Q1 2021 reduction was Microsoft, cutting an estimated $378M.
  • Michael Gelband fully exited Alibaba in Q1 2021, selling an estimated $258M.
  • Michael Gelband's ten largest holdings make up 26% of its $6.86B portfolio in Q1 2021.
  • Michael Gelband opened 973 new positions and closed 811 in Q1 2021.
  • Michael Gelband's portfolio value fell 33% quarter-over-quarter to $6.86B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.